Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Post by mercedesmanon Sep 25, 2024 12:23pm
187 Views
Post# 36240399

Volume and proximity to Top Line

Volume and proximity to Top Line

Took a look at historical share volume on my online trading platform during the period of time of the 2016 run up to Phase 3 data release. 8 years have passed since this event and we are on the eve of another massively consequential event.

Unfortunately I couldn't figure out how to capture/cut/paste the data. 


Observations:

6 months out it was consistently under 500,000 shares per day ( I assume it picks up true volume including dark pools ) - but gradually rising at about 5-6 months out mark. 

3 months out it looked to be averaging between 500k to 800k/ day 

In the last few weeks  there were many well above 1 million share days ( some over 4 million) 

Will history repeat? Not necessarily

Will "Johnny- come- lately's" speculate/participate in the final few months ? Almost for sure. 

How many months left before the Phase 3b top line results are released ( assuming no early takeout)? 
Maybe 5-7 months from now. 

Will longs be selling ? Only some profit takers as and when the price rises. 

Will there be shorting ? Highly unlikely and dangerous 

The share price tripled during the 6 month period leading up to the Phase 3 data release. 


While history may not repeat, longs should take this similar period of time, into account. 


MM 

<< Previous
Bullboard Posts
Next >>